ABCB1 and cancer: Moreover, we discovered that furmonertinib effectively inhibits the drug efflux function of ABCB1 and ABCG2, leading to a substantial restoration of drug-induced apoptosis and reversal of MDR in cancer cells overexpressing these transporters.